Hypersensitivity Reaction to Hyaluronic Acid Dermal Filler Following Novel Coronavirus Infection - a Case Report

Overview

Journal J Cosmet Dermatol

Specialty Dermatology

Date 2021 Mar 18

PMID 33735503

Citations 22

Authors

M J Rowland-Warmann

Affiliations

Soon will be listed here.

Abstract

The incidence of hypersensitivity reactions to hyaluronic acid dermal fillers is between 0.3 and 4.25%, mediated by T-lymphocytes. Flu-like illness can trigger immunogenic reactions at the site of filler placement. Cases of SARS-CoV-2 are significant and pose a possible risk of inducing hypersensitivity. This case report is of a delayed-type hypersensitivity after hyaluronic acid dermal filler treatment of the nose and subsequent infection with SARS-CoV-2. Risk factors for the development of such symptoms were identified as the presence of hyaluronic acid combined with flu-like illness and repeated treatment of one area. The case resolved without intervention. Clinicians should be mindful of the risk posed by the interaction of hyaluronic acid dermal filler with SARS-CoV-2 in light of the pandemic.

Citing Articles

Case report: Improving quality of life through hyaluronic acid-based fillers after orbital cancer treatment.

Egidi S, Valentini V, Schiavetti A Front Oncol. 2025; 14:1501556.

PMID: 39744006 PMC: 11688356. DOI: 10.3389/fonc.2024.1501556.

Etiology of Delayed Inflammatory Reaction Induced by Hyaluronic Acid Filler.

Lee W, Shah-Desai S, Rho N, Cho J Arch Plast Surg. 2024; 51(1):20-26.

PMID: 38425859 PMC: 10901605. DOI: 10.1055/a-2184-6554.

Impact of SARS-CoV-2 Vaccination or Infection on the Safety and Efficacy of Aesthetic Injections: A Systematic Review.

Wu Q, Zhang P, Zhou G, Fu Q, Bai R, Ding H Aesthetic Plast Surg. 2024; 48(12):2343-2352.

PMID: 38302710 DOI: 10.1007/s00266-023-03769-2.

Dermal Filler Hypersensitivity Post-COVID-19 Illness: Case Series and Literature Review.

Wang H, Zhou X, Zheng D Aesthetic Plast Surg. 2023; 48(4):633-637.

PMID: 38057599 DOI: 10.1007/s00266-023-03754-9.

The impact of SARS-Cov-2 infection on the periocular injection pain and hypersensitive reaction to botulinum toxin type A: results from clinical questionnaires.

Liu X, Tian Y, Jiang C, Dong M, Li M, Sun H Front Cell Infect Microbiol. 2023; 13:1240303.

PMID: 37731822 PMC: 10508337. DOI: 10.3389/fcimb.2023.1240303.

References

Roongta R, Ghosh A . Managing rheumatoid arthritis during COVID-19. Clin Rheumatol. 2020; 39(11):3237-3244. PMC: 7474575. DOI: 10.1007/s10067-020-05358-z. View

Ramzi A, Kassim M, George J, Amin A . Dental Procedures: Is it a Risk Factor for Injectable Dermal Fillers?. J Maxillofac Oral Surg. 2015; 14(Suppl 1):158-60. PMC: 4379228. DOI: 10.1007/s12663-012-0398-y. View

Beleznay K, Carruthers J, Carruthers A, Mummert M, Humphrey S . Delayed-onset nodules secondary to a smooth cohesive 20 mg/mL hyaluronic acid filler: cause and management. Dermatol Surg. 2015; 41(8):929-39. DOI: 10.1097/DSS.0000000000000418. View

Heldin P, Karousou E, Bernert B, Porsch H, Nishitsuka K, Skandalis S . Importance of hyaluronan-CD44 interactions in inflammation and tumorigenesis. Connect Tissue Res. 2008; 49(3):215-8. DOI: 10.1080/03008200802143323. View

Tansatit T, Moon H, Rungsawang C, Jitaree B, Uruwan S, Apinuntrum P . Safe Planes for Injection Rhinoplasty: A Histological Analysis of Midline Longitudinal Sections of the Asian Nose. Aesthetic Plast Surg. 2016; 40(2):236-44. DOI: 10.1007/s00266-016-0621-1. View

Madsen S, Chesnut C . Use of Insulin Syringes for Precision Filler in Periocular and Rhinoplasty Procedures. Dermatol Surg. 2019; 46(4):576-578. DOI: 10.1097/DSS.0000000000001832. View

Felsenstein S, Herbert J, McNamara P, Hedrich C . COVID-19: Immunology and treatment options. Clin Immunol. 2020; 215:108448. PMC: 7185015. DOI: 10.1016/j.clim.2020.108448. View

Alijotas-Reig J, Fernandez-Figueras M, Puig L . Inflammatory, immune-mediated adverse reactions related to soft tissue dermal fillers. Semin Arthritis Rheum. 2013; 43(2):241-58. DOI: 10.1016/j.semarthrit.2013.02.001. View

McKean D, Chung S, Fairhead R, Bannister O, Magliano M, Papanikitas J . Corticosteroid injections during the COVID-19 pandemic: experience from a UK centre. Bone Jt Open. 2020; 1(9):605-611. PMC: 7659632. DOI: 10.1302/2633-1462.19.BJO-2020-0130.R1. View

10.

Kumar B, Connors T, Farber D . Human T Cell Development, Localization, and Function throughout Life. Immunity. 2018; 48(2):202-213. PMC: 5826622. DOI: 10.1016/j.immuni.2018.01.007. View

11.

Skevaki C, Fragkou P, Cheng C, Xie M, Renz H . Laboratory characteristics of patients infected with the novel SARS-CoV-2 virus. J Infect. 2020; 81(2):205-212. PMC: 7306198. DOI: 10.1016/j.jinf.2020.06.039. View

12.

Jordan A, Racine R, Hennig M, Lokeshwar V . The Role of CD44 in Disease Pathophysiology and Targeted Treatment. Front Immunol. 2015; 6:182. PMC: 4404944. DOI: 10.3389/fimmu.2015.00182. View

13.

Mikkilineni R, Wipf A, Farah R, Sadick N . New Classification Schemata of Hypersensitivity Adverse Effects After Hyaluronic Acid Injections: Pathophysiology, Treatment Algorithm, and Prevention. Dermatol Surg. 2020; 46(11):1404-1409. DOI: 10.1097/DSS.0000000000002385. View

14.

Gotkin R, Gout U, Sattler S, Piansay-Soriano M, Wanitphakdeedecha R, Ghannam S . Global Recommendations on COVID-19 Vaccines and Soft Tissue Filler Reactions: A Survey-Based Investigation in Cooperation With the International Society for Dermatologic and Aesthetic Surgery (ISDS). J Drugs Dermatol. 2021; 20(4):374-378. DOI: 10.36849/JDD.2021.6041. View

15.

Emmi G, Bettiol A, Mattioli I, Silvestri E, Di Scala G, Urban M . SARS-CoV-2 infection among patients with systemic autoimmune diseases. Autoimmun Rev. 2020; 19(7):102575. PMC: 7200134. DOI: 10.1016/j.autrev.2020.102575. View

16.

Funt D, Pavicic T . Dermal fillers in aesthetics: an overview of adverse events and treatment approaches. Clin Cosmet Investig Dermatol. 2013; 6:295-316. PMC: 3865975. DOI: 10.2147/CCID.S50546. View

17.

Goomer R, Leslie K, Maris T, Amiel D . Native hyaluronan produces less hypersensitivity than cross-linked hyaluronan. Clin Orthop Relat Res. 2005; (434):239-45. DOI: 10.1097/01.blo.0000152443.04202.43. View

18.

Alijotas-Reig J, Fernandez-Figueras M, Puig L . Late-onset inflammatory adverse reactions related to soft tissue filler injections. Clin Rev Allergy Immunol. 2013; 45(1):97-108. DOI: 10.1007/s12016-012-8348-5. View

19.

Youssef J, Novosad S, Winthrop K . Infection Risk and Safety of Corticosteroid Use. Rheum Dis Clin North Am. 2015; 42(1):157-76, ix-x. PMC: 4751577. DOI: 10.1016/j.rdc.2015.08.004. View

20.

De Boulle K, Heydenrych I . Patient factors influencing dermal filler complications: prevention, assessment, and treatment. Clin Cosmet Investig Dermatol. 2015; 8:205-14. PMC: 4404720. DOI: 10.2147/CCID.S80446. View